Dr Rajiv Sankaranarayanan PhD FESC MBBS MRCP

@DrRajivsankar

Father to 2 amazing kids, husband to paediatrician wife,Cardiologist , , sport, , , survivor

Liverpool, England
Vrijeme pridruživanja: ožujak 2009.

Tweetovi

Blokirali ste korisnika/cu @DrRajivsankar

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @DrRajivsankar

  1. prije 16 sati
    , , i još njih 7
    Poništi
  2. Poništi
  3. 5. velj

    SGLT2i for patients with T2DM and CKD⤵️ 📍trials supports the role of SGLT2i to prevent kidney and CV events in 👥 with T2DM ➡️lower levels of eGFR and higher levels of albuminuria are among those who stand to gain the greatest absolute benefits

    , , i još njih 7
    Poništi
  4. prije 16 sati

    ⚠️ Diabetes in patients with HFrEF is associated with distinct pathophysiological pathways related to inflammation. 📌 These data support the evaluation of anti-inflammatory therapeutic approaches

    , , i još njih 7
    Poništi
  5. prije 17 sati

    New State-of-the-Art Review: Could this be a game changer in treatment? Check out the methods paper for the trial, which explores the effect of omecamtiv mecarbil, a novel cardiac myosin activator, in chronic .

    Poništi
  6. 4. velj

    Max fixed energy shocks vs escalated shocks in DCCV for AF - First presented at ESC Congress 2019. Now in this weeks EHJ edition. That's a reminder that ESC Congress 2020 abstract deadline is fast approaching!!!

    Poništi
  7. 4. velj

    HF awareness week--critical to raise awareness of this disease thats common, highly morbid, and on the rise--exciting new treatments available but have to raise awareness to impact public health

    Poništi
  8. Macrovascular Endothelial Dysfunction beyond effect of & T2 alone: Investigators recommend including assessment of in future T2D trials You would agree

    Prikaži ovu nit
    Poništi
  9. 3. velj

    Heart Failure Awareness Week kicks off THIS WEEKEND! We'll be tweeting all this week, sharing ways you can participate. ❤️☑️ Make sure you're signed up to be a promoter on social media via our PostSpeaker campaign.

    Prikaži ovu nit
    Poništi
  10. 4. velj

    REDUCE-IT USA now published in print in Circulation! Mortality reduction seen in this cohort with multiple cardiovascular risk factors.

    Poništi
  11. is the major cause of mortality in elderly women diagnosed with cancer with a 30% increased risk of cardiovascular events particularly

    Poništi
  12. 4. velj

    Acute kidney injury and adverse renal events in patients receiving SGLT2-inhibitors: A systematic review and meta-analysis

    Poništi
  13. 1. velj

    Dr. Sana Al-Khatib: do you know and EP who is a Preventive Cardiologist? She is one! ♥️lower rates of SCD in 💃🏻: autopsy data 21%💃🏻 vs 79% 👨 ♥️ICDs save lives but used less in 💃🏻 ♥️her work supports lower mortality in 💃🏻 with ICD

    Prikaži ovu nit
    Poništi
  14. Empagliflozin in ADHF: no effect on change in VAS dyspnoea, diuretic response, NT‐proBNP, and length of hospital stay, but ⬆️ urinary output and ⬇️combined endpoint of worsening HF, rehospitalization for HF or death at 60d

    Prikaži ovu nit
    Poništi
  15. 31. sij

    We are delighted to announce details for our Heart Failure: Don’t Fail to Function Masterclass, 12 Jun 2020, London have been published and registration is now open. To register or find out more details about this event, please see our website

    Poništi
  16. 1. velj

    Great choice by In this article effect magnitude of Dapaglifozin is compared with recent therapies in RCTs such as PARADIGM-HF, SHIFT & EMPHASIS-HF

    Prikaži ovu nit
    Poništi
  17. Odgovor korisnicima i sljedećem broju korisnika:

    is buzzing with discussion on coronary microvascular dysfunction! Timely for today 02-02-2020 👇with Editor @CircOutcome

    Poništi
  18. Poništi
  19. 1. velj

    Ongoing trials are addressing the role of SGLT2i in patient with HF and preserved ejection fraction and chronic kidney disease,with and without T2DM

    Prikaži ovu nit
    Poništi
  20. 1. velj

    can break down a complicated issue so wonderfully. She came so far for us today &. I am so proud to know her. Thank you for your efforts dear Harriette! You made my CME amazing!

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·